ALZN
ALZN clinical trials: Alzamend Neuro, Inc.
Every trial on ClinicalTrials.gov where Alzamend Neuro, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ALZN on the catalyst calendar · ALZN registry changes
- Primary completion Jul 2027Sponsor estimatePhase 1/Phase 2NCT07540338A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed...Alzamend Neuro, Inc. · Bipolar I DisorderActive, not recruitingALZNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 3, 2028Sponsor estimatePhase 1/Phase 2NCT05834296Study in Subjects With Mild-to-Moderate Alzheimer's DementiaAlzamend Neuro, Inc. · Alzheimer DiseaseActive, not recruitingALZNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2025ActualPhase 1NCT06921590A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed...Alzamend Neuro, Inc. · PharmacokineticsCompletedALZNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 14, 2023ActualPhase 1/Phase 2NCT05363293Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult SubjectsAlzamend Neuro, Inc. · Alzheimer's DiseaseCompletedALZNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner